Summary
This investigation reports for the first time the establishment of immortalized clones of dopamine-producing nerve cells in culture. Freshly prepared single-cell suspensions from fetal (12-day-old) rat mesencephalic tissue were transfected with plasmid vectors, pSV3neo and pSV5neo, using an electroporation technique. Cells were plated in tissue culture dishes which were precoated with a special substrate and contained modified MCDB-153 growth medium with 10% heat inactivated fetal bovine serum. The immortalized cells were selected by placing the transfected cells in a selection medium (modified MCDB-153 containing 400µg/ml geneticin). The survivors showed the presence of T-antigens and were non-tumorigenic. Two cell lines, 1RB3 derived from cells transfected with pSV3neo, and 2RB5 derived from cells transfected with pSV3neo, revealed only 1 to 2% tyrosine hydroxylase (TH)-positive cells. Repeated single-cell cloning of these cell lines by a standard technique failed to increase the number of TH-positive cells in any clones. Using three cycles of growth, alternating between hormone-supplemented, serum-free medium and serum-containing medium produced a cell line (1RB3A) that was very rich in TH-positive cells. The recloning of 1RB3A yielded clones some of which contained over 95% TH-positive cells. These cells produced homovanillic acid, a metabolite of dopamine, and may be useful not only for neural transplant but also for basic neurobiological studies.
References
Allen, G. S.; Burns, R. S.; Tulpan, N. B., et al. Adrenal medullary transplantation to the caudate nucleus in Parkinson’s disease: initial clinical results in 18 patients. Arch. Neurol. 46:487–491; 1989.
Bakay, R. A. E.; Barrow, D. L.; Fiandaca, M. S., et al. Biochemical and behavioral correction of MPTP-like syndrome by fetal cell transplantation. Ann. NY Acad. Sci. 495:623–640; 1987.
Bartelett, P. F.; Reid, H. H.; Bailey, K. A., et al. Immortalization of mouse neural precursor cells by the c-myc oncogene. Proc. Natl. Acad. Sci. USA 85:3255–3259; 1988.
Bernard, O.; Reid, H. H.; Bartlett, P. F. Role of the c-myc and the N-myc oncogenes in the immortalization of neural precursors. J. Neurosci. Res. 24:9–20; 1989.
Bjorklund, A.; Stenevi, U. Reconstruction of the nigrostriatial dopamine pathway by intracerebral nigral transplants. Brain Res. 177:555–560; 1979.
Bohn, M. C.; Cupit, L.; Marciano, F., et al. Adrenal medulla graft enhanced recovery of striatal dopaminergic fibers. Science 237:913–916; 1987.
Bottenstein, J. E.; Sato, G. H. Growth of a rat neuroblastoma cell line in serum free supplemented medium. Proc. Natl. Acad. Sci. USA 76:514–517; 1979.
Choi, H. K.; Won, I. A.; Kontur, P. I., et al. Immortalization of embryonic mesencephalic dopaminergic neurons by somatic cell fusion. Brain Res. 552:67–76; 1991.
Dunnett, S. B.; Annett, L. E. Nigral transplants in primate model of Parkinsonism. In: Lindvall, O., Bjorklund, A., Widner, H., eds. Intracerebral transplantation in movement disorders, vol. 4. Restorative neurology and neuroscience. Amsterdam: Elsevier; 1991:27–51.
Dunnett, S. B.; Hernandez, T.; Summerfield, A., et al. Graft-derived recovery from 6-0HDA lesions: specificity of ventral mesencephalic graft tissues. Exp. Brain Res. 71:411–424; 1988.
Evrard, C.; Borde, I.; Marin, P., et al. Immortalization of bipotential and plastic glia—neuronal precursor cells. Proc. Natl. Acad. Sci. USA 87:3062–3066; 1990.
Freed, C. R.; Breeze, R. E.; Rosenberg, N. L., et al. Transplantation of human fetal dopamine cells for Parkinson’s disease. Arch. Neurol. 47:505–512; 1990.
Freed, C. R.; Breeze, T. E.; Rosenberg, N. L., et al. Survival of implanted fetal dopamine cells and neurological improvement 12 to 46 months after transplantation for Parkinson’s disease. N. Engl. J. Med. 327:1549–1555; 1992.
Freed, W. J.; Poltorak, N.; Becker, J. B. Intracerebral adrenal medulla grafts: a review. Exp. Neurol. 110:39–166; 1990.
Galiana, E.; Borde, I.; Marin, P., et al. Establishment of permanent astroglia cell lines, able to differentiate in vitro, from transgenic mice carrying the polyoma virus large T-gene: An alternative approach to brain cell immortalization. J. Neurosci. Res. 26:269–277; 1990.
Gash, D. M.; Collier, T. J.; Sladek, J. R., Jr. Neural transplantation: a review of recent developments and potential application to aged brain. Neurobiol. Aging 6:131–150; 1985.
Goetz, C. G.; Olanow, C. W.; Koller, W. C., et al. Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson’s disease. N. Engl. J. Med. 320:337–341; 1989.
Henderson, B. T. H.; Clough, C. G.; Hughes, R. C., et al. Implantation of human fetal ventral mesencephalon to the right caudate nucleus in advanced Parkinson’s disease. Arch. Neurol. 48:822–827; 1991.
Kentroti, S.; Vernadakis, A. Growth hormone—releasing hormone influences neural expression in the developing chick brain. I. Catecholaminergic neurons. Dev. Brain Res. 49:275–280; 1989.
Kordower, J. H.; Fiandaca, M. S.; Notter, M. F. D., et al. Scientific basis for dopaminergic brain grafting. In: Koller, W. C.; Paulson, G., eds. Therapy of Parkinson’s disease. New York: Marcel Dekker, Inc.; 1990:443–472.
La Rosa, F. G.; Talmage, D. W. Major histocompatability complex antigen expression on parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection. Transplantation 49:605–609; 1990.
Lechner, J. F.; LaVeek, M. A. A serum-free method for culturing normal human bronchial epithelial cells at clonal density. J. Tissue Cult. Methods 9:43–48; 1985.
Lindvall, O.; Rehncrona, S.; Brundin, P., et al. Human fetal dopamine neurons grafted into striatum in two patients with severe Parkinson’s disease. Arch. Neurol. 46:615–631; 1989.
Lindvall, O.; Backlund, E-O.; Farde L., et al. Transplantation in Parkinson’s disease: two cases of adrenal medullary grafts to the putamen. Ann. Neurol. 22:457–468; 1987.
Lindvall, O.; Brundin, P.; Widner, H., et al. Graft of fetal dopamine neurons survive and improve motor function in Parkinson’s disease. Science 247:547–577; 1990.
Lindvall, O.; Widner, H.; Rehncrona, S., et al. Transplantation of fetal dopamine neurons in Parkinson’s disease: one-year clinical and neurophysiological observations in two patients with putaminal implants. Ann. Neurol. 31:155–165; 1992.
Lowry, O. H.; Rosebrough, N. J.; Farr, A. L., et al. Protein measurement with Folin Phenol reagent. J. Biol. Chem. 193:265–275; 1951.
Madrazo, I.; Leon, V.; Torres, C., et al. Transplantation of fetal substantia nigra and adrenal medulla to the caudate nucleus in two patients with Parkinson’s disease. N. Engl. J. Med. 318:51; 1988.
Madrazo, I.; Drucker-Colin, R.; Diaz, B., et al. Open microsurgical autograft of adrenal medulla to the right caudate nucleus in two patients with intractable Parkinson’s disease. N. Engl. J. Med. 316:831–834; 1987.
Madrazo, I.; Franco-Bourland, R.; Ostrosky-Solis, F., et al. Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects. Arch. Neurol. 48:1281–1285; 1990.
Masserano, J. M.; Takimoto, A. S.; Weiner, N. Tyrosine hydroxylase activity in the brain and adrenal gland of rats following chronic administrations of ethanol. Alcohol Clin. Exp. Res. 7:294–298; 1983.
Mugele, K.; Kugler, H.; Spiess, J. Immortalization of a fetal rat brain cell line that expresses corticotropin releasing factor mRNA. DNA Cell Biol. 12:119–126; 1993.
Prasad, K. N. Differentiation of neuroblastoma cells: a useful model for neurobiology and cancer. Biol. Rev. 66:431–451; 1991.
Prasad, K. N.; Carvalho, E.; Kentroti, S., et al. Production of terminally differentiated neuroblastoma cells in culture. Rest. Neurol. Neurosci. In press; 1994.
Prasad, K. N.; Kentroti, S.; Edwards-Prasad, J., et al. Modification of the expression of adenosine 3′, 5′-cyclic monophosphate—induced differentiated functions in neuroblastoma cells by beta-carotene and d-alpha-tocopheryl succinate. J. Am. Coll. Nutr. (In press); 1994.
Perlow, M. J.; Freed, W. J.; Hoffer, B. J., et al. Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. Science 204:643–647; 1979.
Pirisi, L.; Yasumoto, S.; Feller, M., et al. Transformation of human fibroblasts and keratinocytes with human papilloma virus type 16 DNA. J. Virol. 61:1061–1066, 1987.
Sawle, G. V.; Bloomfield, P. M.; Bjorklund, A., et al. Transplantation of fetal dopamine neurons in Parkinson’s disease: PET (18F)-6-l-fluorodopa studies in two patients with putaminal implants. Ann. Neurol. 31:166–173; 1992.
Southern, P. J.; Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J. Mol. Appl. Genet. 1:327–341; 1982.
Sternberger, L. A.; Hardy, P. H., Jr.; Cuculis, J. J., et al. Unlabeled antibody-enzyme method of immunocytochemistry. Preparations and properties of soluble antigen-antibody complex (horse radish peroxidase-anti-horse radish peroxidase) and its use in the identification of spirochetes. J. Histochem. Cytochem. 18:315–333; 1970.
Tandon, P. N.; Gopinath, G.; Mahapatra, A. K., et al. Neural transplantation in mammals: our experience. Proc. Indian Acad. Sci. B56:551–558; 1990.
Widner, H.; Brundin, P. Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res. Rev. 13:287–324; 1988.
Yurek, D.; Sladek, J. R., Jr. Dopamine cell replacement: Parkinson’s disease. Ann. Rev. Neurosci. 13:415–440; 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prasad, K.N., Carvalho, E., Kentroti, S. et al. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol - Animal 30, 596–603 (1994). https://doi.org/10.1007/BF02631258
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02631258